ZNTL — Zentalis Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Zentalis Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	339	340	437	483	371
Net Total Accounts Receivable
Net Total Receivables	0.417	0.004	—	—	5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	345	351	452	497	386
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.62	52.8	50.1	41.7	37.2
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	366	455	539	552	430
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	28.6	43.9	56.6	69.4	52.7
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	57	90.6	106	114	93.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	309	364	434	437	337
Total Liabilities & Shareholders' Equity	366	455	539	552	430
Total Common Shares Outstanding